French Other Utilities Stock News

ENXTPA:NEX
ENXTPA:NEXElectrical

Is Nexans (ENXTPA:NEX) Still Attractive After Strong Five Year Share Price Gains?

If you are wondering whether Nexans at €136 is still offering value or if most of the opportunity is already reflected in the price, you are not alone. The stock has recent returns of 3.6% over 7 days, 7.3% over 30 days, 6.0% year to date, 49.8% over 1 year and 50.2% over 3 years, with a 128.8% return over 5 years shaping how investors think about its potential and risk today. Recent coverage has focused on Nexans' role in power and infrastructure projects, along with market attention on...
ENXTPA:AIR
ENXTPA:AIRAerospace & Defense

Airbus Balances Toxic Air Lawsuit With Refueling Breakthrough And Green Power Deals

Airbus is facing a major lawsuit from a US flight attendant alleging long term illness from toxic fumes on an Airbus A319. The company has secured full certification for the world's first automatic air to air refueling system on its A330 MRTT. Airbus and TotalEnergies have signed renewable power purchase agreements that support Airbus's decarbonisation plans. For investors tracking ENXTPA:AIR, these headlines arrive with the shares at €189.52 and a mixed recent performance, including a 9.5%...
ENXTPA:ENGI
ENXTPA:ENGIIntegrated Utilities

Is Engie (ENXTPA:ENGI) Still Attractively Priced After A 76% One Year Rally?

If you are wondering whether Engie shares still offer value after a strong run, this article walks through what the current price might be implying. Engie’s share price recently closed at €25.47, with returns of 2.4% over 7 days, 9.5% over 30 days, 10.9% year to date, 75.7% over 1 year and 185.3% over 5 years, which naturally raises questions about what is already priced in. Recent news around Engie has focused on its role as a major European utilities group and ongoing attention on energy...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Sanofi (ENXTPA:SAN) Is Up 5.2% After GD3 Neurology Trial Win - Has The Bull Case Changed?

Sanofi recently reported that its investigational oral therapy venglustat met the primary and most key secondary endpoints in the phase 3 LEAP2MONO study for type 3 Gaucher disease, showing statistically significant neurological benefits versus enzyme replacement therapy and prompting plans for global regulatory filings. The readout is particularly important because it targets neurological manifestations of GD3, an area with no approved treatments despite long-standing systemic...
ENXTPA:ACA
ENXTPA:ACABanks

Crédit Agricole (ENXTPA:ACA) Net Margin Resilience Challenges Cautious Earnings Narratives

Crédit Agricole (ENXTPA:ACA) has wrapped up FY 2025 with fourth quarter revenue of €6,788 million and basic EPS of €0.35, setting the tone for how investors are reading the full year. Over recent quarters, the group has seen revenue move from €6,843 million in Q1 2025 to €6,565 million in Q2 and €6,361 million in Q3. EPS shifted from €0.56 to €0.75 and €0.58 over the same periods, giving a clear view of how the top line and EPS have tracked through the year. With a trailing net profit margin...
ENXTPA:DEC
ENXTPA:DECMedia

JCDecaux Expands Global Programmatic DOOH Offer As Investors Weigh Valuation

JCDecaux has launched what it calls the world's first global programmatic Digital Out-of-Home media solution. The offer extends beyond airports to include streets, transport hubs, and retail environments across multiple countries. The new platform is designed to give advertisers programmatic tools for targeting, real time activation, and campaign measurement on a worldwide scale. JCDecaux (ENXTPA:DEC), trading at €16.55, is already a major player in outdoor advertising, and this move into...
ENXTPA:LR
ENXTPA:LRElectrical

Legrand (ENXTPA:LR) Valuation Snapshot After Recent Pullback And Strong One Year Return

Legrand share performance snapshot Legrand (ENXTPA:LR) has drawn fresh attention after recent price moves, with the stock showing a 1.7% decline over the last day but positive returns over the past week, month and past 3 months. See our latest analysis for Legrand. That short term pullback sits against a steadier backdrop, with a year to date share price return of 5.5% and a 1 year total shareholder return of 45.7%. This suggests that momentum has largely been building rather than fading. If...
ENXTPA:ERF
ENXTPA:ERFLife Sciences

Eurofins Expands US Lab Network And AI Capabilities For Higher Value Work

Eurofins Scientific (ENXTPA:ERF) has opened a new 60,000 square foot Eurofins MET Laboratories testing facility in Massachusetts. The site expands capabilities in product safety, EMC and wireless, and renewable energy testing for medical devices, wireless tech, and clean energy clients. Eurofins CDMO Alphora has also introduced AI powered pharmaceutical screening software aimed at more efficient drug substance analysis. Eurofins Scientific, known for its global laboratory and testing...
ENXTPA:DG
ENXTPA:DGConstruction

Should Jamaica Water Resilience Contract Reshape Vinci’s (ENXTPA:DG) Long-Term Infrastructure Narrative?

Jamaica's National Water Commission recently selected VINCI Construction Grands Projets to deliver a €144 million contract to design and build 68 km of wide cast-iron pipeline over nearly 130 km of roadway, as part of phase 1 of the Western Water Resilience Programme to upgrade the north-west drinking water network. This long-duration project, focused on durable materials and climate resilience, underlines VINCI's growing role in complex water infrastructure and environmental protection in...
ENXTPA:SOI
ENXTPA:SOISemiconductor

Soitec (ENXTPA:SOI) Valuation After Earnings Reveal Mixed Revenue Trends And 20% Growth Guidance

Soitec (ENXTPA:SOI) is back in focus after its latest trading statement, which combined an 18% sequential revenue increase with a 29% year-on-year decline and fresh guidance indicating around 20% growth next quarter. See our latest analysis for Soitec. The trading update arrived alongside sharp short term price moves, with a 1 day share price return of 23.3% and a 7 day gain of 10%. However, the 1 year total shareholder return of a 63.2% decline indicates that longer term momentum has been...
ENXTPA:GET
ENXTPA:GETInfrastructure

Assessing Getlink (ENXTPA:GET) Valuation After A Steady Revenue Update And Stronger Recent Returns

What the latest trading update means for Getlink (ENXTPA:GET) Getlink (ENXTPA:GET) has just released unaudited revenue figures showing fourth quarter revenue of €384 million versus €325 million a year earlier, while full year 2025 revenue stayed close to €1,595 million versus €1,605 million. See our latest analysis for Getlink. The trading update comes after a steady run in the share price, with a 90 day share price return of 9.22% and a 1 year total shareholder return of 14.34%. This...
ENXTPA:BN
ENXTPA:BNFood

Danone Infant Formula Recall Tests Food Safety Reputation And Investor Views

Danone has initiated a targeted recall of specific infant formula batches, following updated guidance from local food safety authorities. The recall focuses on precautionary food safety measures and is being communicated as a proactive compliance step. Management has emphasized transparency with regulators, healthcare professionals and consumers as the recall process unfolds. For investors watching Danone (ENXTPA:BN), the recall comes with the share price around €71.88 and a 7 day return of...
ENXTPA:RI
ENXTPA:RIBeverage

A Look At Pernod Ricard’s Valuation As New Leadership Structure Takes Shape

Pernod Ricard (ENXTPA:RI) has reshaped its leadership structure, promoting Irish Distillers CEO Nodjame Fouad to lead the new Gold brand unit and Stéphanie Durroux to head the Crystal unit for unaged spirits. See our latest analysis for Pernod Ricard. The leadership reshuffle arrives alongside a sharp short term rebound in sentiment, with a 1 month share price return of 8.96% and a 1 day move of 5.01%. However, the 1 year total shareholder return of a 17.42% decline and the 5 year total...
ENXTPA:PUB
ENXTPA:PUBMedia

Publicis Groupe Ties Cancer Support And AI Push To Long Term Story

Publicis Groupe (ENXTPA:PUB) has expanded its global "Working with Cancer" program, adding new tools and policies to support employees affected by cancer. The company introduced an AI powered coaching tool and drew on research from leading cancer centers to shape its approach. In the Middle East, Publicis Groupe launched "The Majlis of Possible," a platform aimed at bringing together government and private sector leaders. These moves come alongside ongoing work by Publicis Groupe to apply...
ENXTPA:SCR
ENXTPA:SCRInsurance

SCOR January Renewals Highlight P&C Growth And Alternative Solutions Shift

SCOR (ENXTPA:SCR) reports significant growth in its Property & Casualty portfolio during the January 2026 renewals. The company highlights strong traction in Alternative Solutions alongside expansion in traditional reinsurance. Management stresses that underwriting discipline was maintained in what it describes as a competitive market environment. For you as an investor, the key point is that January renewals are a critical moment for global reinsurers, setting the tone for a large portion...
ENXTPA:AC
ENXTPA:ACHospitality

Is Accor (ENXTPA:AC) Using Fairmont Hanoi to Quietly Recast Its Premium Asia Strategy?

Accor’s Fairmont Hotels & Resorts brand has opened Fairmont Hanoi, its first Fairmont property in Vietnam, a 241-room luxury hotel in Hanoi’s Old Quarter with extensive dining, wellness, and event facilities including the area’s largest pillarless ballroom. This launch expands Accor’s high-end footprint in Southeast Asia and positions Fairmont Hanoi as a dual-purpose destination for both business events and premium leisure travel. We’ll now examine how Fairmont Hanoi’s focus on both business...
ENXTPA:CDI
ENXTPA:CDILuxury

Christian Dior (ENXTPA:CDI) Valuation After Annual Results Reveal Lower Sales And Profits

Christian Dior (ENXTPA:CDI) has drawn investor attention after reporting full year 2025 results, with sales of €80.8b and net income of €4.5b, both lower than the prior year’s figures. See our latest analysis for Christian Dior. At a share price of €504.5, Christian Dior’s recent 30 day share price return of 15.64% decline and 90 day share price return of 10.15% decline suggest momentum has been weak, a pattern that aligns with its 18.30% one year total shareholder return decline and 31.61%...
ENXTPA:BVI
ENXTPA:BVIProfessional Services

Does EcoVadis Accreditation Reshape Bureau Veritas’ Sustainability Edge and Investment Case (ENXTPA:BVI)?

In January 2026, EcoVadis named Bureau Veritas as an Accredited Consulting Partner, formally recognizing its capability to guide companies through sustainability assessments, score reviews, and improvements across environmental, labor and human rights, ethics, and sustainable procurement practices. This accreditation deepens Bureau Veritas’ role in supply chain sustainability by combining compliance, risk management, and transformation services to help businesses embed responsible sourcing,...